Literature DB >> 2379011

Enalapril and metoprolol in diabetic nephropathy.

P Sawicki, L Heinemann, I Mühlhauser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2379011      PMCID： PMC1663162          DOI： 10.1136/bmj.300.6737.1466-a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus?

Authors:  P T Sawicki; I Mühlhauser; T Baba; M Berger
Journal:  Diabetologia       Date:  1990-02       Impact factor: 10.122

2.  Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy.

Authors:  S Björck; G Nyberg; H Mulec; G Granerus; H Herlitz; M Aurell
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-23

3.  Controlled, randomised trial of the effect of dietary fat on blood pressure.

Authors:  P Puska; J M Iacono; A Nissinen; H J Korhonen; E Vartianinen; P Pietinen; R Dougherty; U Leino; M Mutanen; S Moisio; J Huttunen
Journal:  Lancet       Date:  1983-01-01       Impact factor: 79.321

4.  Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.

Authors:  S Björck; H Mulec; S A Johnsen; G Nyberg; M Aurell
Journal:  BMJ       Date:  1990-04-07
  4 in total
  1 in total

1.  Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus?

Authors:  K Rett; P T Sawicki
Journal:  Diabetologia       Date:  1991-02       Impact factor: 10.122
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.